Targeting sphingosine-1-phosphate signaling in lung diseases-Reference-Cited by-同舟云学术

Targeting sphingosine-1-phosphate signaling in lung diseases

Published:2016-12 Issue: Volume:168 Page:143-157
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Ebenezer David L.,Fu Panfeng,Natarajan Viswanathan

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference230 articles.

1. High-risk mesothelioma relation to meteorological and geological condition and distance from naturally occurring asbestos;Abakay;Environ Health Prev Med,2015

2. Sphingolipids in lung endothelial biology and regulation of vascular integrity;Abbasi;Handb Exp Pharmacol,2013

3. Plasma sphingolipids and lung cancer: a population-based, nested case–control study;Alberg;Cancer Epidemiol Biomark Prev,2013

4. Regulation and functional roles of sphingosine kinases;Alemany;Naunyn Schmiedeberg's Arch Pharmacol,2007

5. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking;Allende;J Biol Chem,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystathionine γ-lyase-derived H2S negatively regulates thymic egress via allosteric inhibition of sphingosine-1-phosphate lyase;Acta Pharmacologica Sinica;2024-06-24

2. Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis;Respiratory Research;2024-06-17

3. Exploring SK/S1P/S1PR pathway as a target for antiviral drug development;Health Sciences Review;2024-06

4. 1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management;International Immunopharmacology;2024-04

5. Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases;Biomedicines;2024-01-08